Stratos Investment Management LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 412 shares of the medical equipment provider’s stock, valued at approximately $215,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Bennett Selby Investments LP grew its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC grew its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its holdings in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the last quarter. FSM Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC boosted its position in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after buying an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of research reports. UBS Group boosted their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. CICC Research initiated coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Jefferies Financial Group boosted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.
Intuitive Surgical Trading Up 1.9 %
ISRG opened at $590.90 on Thursday. The company’s fifty day moving average price is $551.99 and its two-hundred day moving average price is $512.04. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market cap of $210.47 billion, a price-to-earnings ratio of 92.18, a PEG ratio of 5.51 and a beta of 1.39.
Insiders Place Their Bets
In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 28,843 shares of company stock worth $15,357,560. Insiders own 0.80% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Most Volatile Stocks, What Investors Need to Know
- 3 Must-Have ETFs Set to Dominate This Quarter
- What is the Nasdaq? Complete Overview with History
- Seeking Stability? These 3 Stocks Offer Strong Potential
- What is a Stock Market Index and How Do You Use Them?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.